CELLF BIO Achieves Milestone With First In Human Implantation of BioSphincter
| DNLYX Fund | USD 58.42 0.73 1.27% |
Slightly above 51% of Dreyfus Active's investors are presently thinking to get in. The analysis of overall sentiment of trading Dreyfus Active Midcap mutual fund suggests that some investors are interested at this time. Dreyfus Active's investing sentiment can be driven by a variety of factors including economic data, Dreyfus Active's earnings reports, geopolitical events, and overall market trends.
Dreyfus |
RICHMOND, Va., June 06, 2023 CELLF BIO achieved a major milestone with the worlds first human implantation of BioSphincter, an autologous bioengineered sphincter made of smooth muscle and differentiated neural stem cells. The Phase 1 clinical trial is being conducted to treat patients with fecal incontinence , a condition that affects millions of people worldwide. The implantation surgery was performed by Dr. Jaime Bohl, chief of colon and rectal surgery at the Virginia
Read at finance.yahoo.com
 |
Dreyfus Active Fundamental Analysis
We analyze Dreyfus Active's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dreyfus Active using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dreyfus Active based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Ten Year Return
Ten Year Return Comparative Analysis
Dreyfus Active is currently under evaluation in ten year return among similar funds. Ten Year Return shows the total annualized return generated from holding a fund for the last 10 years and represents fund's capital appreciation, including dividends losses and capital gains distributions. This return indicator is considered by many investors to be the ultimate measures of fund performance and can reflect the overall performance of the market or market segment it invests in.
Dreyfus Active Midcap Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Dreyfus Active mutual fund to make a market-neutral strategy. Peer analysis of Dreyfus Active could also be used in its relative valuation, which is a method of valuing Dreyfus Active by comparing valuation metrics with similar companies.
Peers
Dreyfus Active Related Equities
| SMPIX | Semiconductor Ultrasector | 2.71 | ||||
| APDOX | Artisan Emerging | 0.49 | ||||
| OWSBX | Old Westbury | 0.20 | ||||
| MDMTX | Blrc Sgy | 0.19 | ||||
| RALVX | Growth Strategy | 0.08 | ||||
| POEIX | Origin Emerging | 0.1 | ||||
| OPTCX | Rbb Fund | 0.21 |
Other Information on Investing in Dreyfus Mutual Fund
Dreyfus Active financial ratios help investors to determine whether Dreyfus Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Dreyfus with respect to the benefits of owning Dreyfus Active security.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |